In addition, LMF-HSFx enhancing the leptin and adiponectin expression in NAFLD patients suggested that LMF-HSFx may modulate adipogenesis in NAFLD patients. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.